CVE-2023-24958

CVE-2023-24958 is a high-severity vulnerability in Ibm 3957-vec Firmware with a CVSS 3.x base score of 8.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-78.

Key facts

Description

A vulnerability in the IBM TS7700 Management Interface 8.51.2.12, 8.52.200.111, 8.52.102.13, and 8.53.0.63 could allow an authenticated user to submit a specially crafted URL leading to privilege escalation and remote code execution. IBM X-Force ID: 246320.

Frequently asked questions

What is CVE-2023-24958?
A vulnerability in the IBM TS7700 Management Interface 8.51.2.12, 8.52.200.111, 8.52.102.13, and 8.53.0.63 could allow an authenticated user to submit a specially crafted URL leading to privilege escalation and remote code execution. IBM X-Force ID: 246320.
How severe is CVE-2023-24958?
CVE-2023-24958 has a CVSS 3.x base score of 8.8, rated high severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2023-24958 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (61st percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-24958?
CVE-2023-24958 primarily affects Ibm 3957-vec Firmware. In total, 3 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2023-24958?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2023-24958 published?
CVE-2023-24958 was published on 2023-05-04 and last updated on 2026-06-17.

References

Affected products (3)

Other CWE-78 (OS Command Injection) vulnerabilities

Browse all CWE-78 (OS Command Injection) vulnerabilities →